Althea shares tumble after announcing $2m capital raise for product expansion by Steve Jones July 16, 2024July 17, 2024 Althea has completed a A$2 million placement with the funds set aside for growing its recreational […]
Company news: ECS Botanics; Althea; InhaleRx; Neurotech International by Martin Lane and Steve Jones July 10, 2024July 11, 2024
Senior team confirmed as Althea eyes emerging European markets by Steve Jones June 26, 2024June 26, 2024
Althea makes further savings as cost-cutting program continues by Steve Jones April 30, 2024April 30, 2024
Company news: Cann Compounding; Ecofibre; Ora Pharm; Althea; Melodiol Global Health; Wellnex Life; Emyria by Martin Lane and Steve Jones April 24, 2024November 25, 2024
Company news: Medibis; Althea; Elixinol; InhaleRx; Ecofibre; Aura Therapeutics; AusCann by Martin Lane April 4, 2024July 16, 2024
Althea announces job cuts worth A$1.5m with more savings to come by Martin Lane March 28, 2024March 28, 2024
Althea to cut further costs amid cash flow concerns and ongoing losses by Steve Jones March 1, 2024March 4, 2024
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024November 25, 2024
‘Like it or not, drugs are part of society’: Penington Institute urges ‘cautious approach’ to legalisation by Steve Jones November 13, 2023April 30, 2024
